Form 4 for PCVX Vaxcyte, Inc.
Accepted 2022-03-23 00:00:00 ET · period of report 2022-03-21 · accession 0001209191-22-020815 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-03-23 | 2022-03-21+ | PCVX | PICKERING GRANT | CEO, Dir | S - Sale+OE | $24.83 | -22.0K | 703.9K | -3% | -$546.2K |
| DM | 2022-03-23 | 2022-03-21+ | PCVX | PICKERING GRANT | CEO, Dir | M - OptEx | $1.79 | +22.0K | 711.6K | +3% | +$39.4K |
| DM | 2022-03-23 | 2022-03-21+ | PCVX | PICKERING GRANT | CEO, Dir | M - OptEx | $0.00 | -22.0K | 256.4K | -8% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-21 | S | D | 13,929 | $24.92 | 704,253 | D | — | — | (F2) The price reported is a weighted-average price. The shares were sold at prices ranging from $24.55 to $25.48. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2022-03-21 | M | A | 14,288 | $1.79 | 718,182 | D | — | — | |
| 3 | Common | Common Stock | 2022-03-21 | S | D | 359 | $25.68 | 703,894 | D | — | — | (F3) The price reported is a weighted-average price. The shares were sold at prices ranging from $25.635 to $25.70. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 4 | Common | Common Stock | 2022-03-22 | M | A | 7,712 | $1.79 | 711,606 | D | — | — | |
| 5 | Common | Common Stock | 2022-03-22 | S | D | 7,712 | $24.62 | 703,894 | D | — | — | (F4) The price reported is a weighted-average price. The shares were sold at prices ranging from $24.20 to $25.02. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 6 | Derivative | Stock Option (right to buy) | 2022-03-21 | M | D | 14,288 | $0.00 | 264,162 | D | $1.79 · — to 2027-05-17 | 14,288 Common Stock | (F5) The shares subject to the option are fully vested and exercisable. |
| 7 | Derivative | Stock Option (right to buy) | 2022-03-22 | M | D | 7,712 | $0.00 | 256,450 | D | $1.79 · — to 2027-05-17 | 7,712 Common Stock | (F5) The shares subject to the option are fully vested and exercisable. |